Deborah Mitsuko Kado, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kado’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G76662 · Current
Licensed to practise in California · since 1993 · expires 2027-05-31 · Cornell University Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Geriatric Medicine
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Drugs they prescribed that Part D paid
$266
Pharmacies billed $266 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 23) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
23 generic and 0 brand-name prescriptions · $266 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Alendronate | 23 | $266 | $12 |
Year by year
| 2024 | 23 | None | 0% (0) | 0% | $266 |
| 2023 | 81 | 22 | 0% (0) | None | $35,807 |
| 2022 | 64 | 18 | 0% (0) | None | $54,351 |
| 2020 | 128 | 26 | 0% (0) | None | $1,018,705 |
| 2019 | 128 | 33 | 0% (0) | None | $854,679 |
| 2018 | 149 | 25 | 0% (0) | 42% | $223,248 |
| 2017 | 148 | 29 | 0% (0) | 49% | $258,699 |
| 2016 | 116 | 26 | 0% (0) | None | $136,269 |
| 2015 | 71 | 26 | None | 32% | $26,804 |
| 2014 | 76 | 17 | 0% (0) | 24% | $9,388 |
| 2013 | 140 | 33 | None | None | $19,642 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Alendronate | 66 | $807 | $12 |
2022: 1 drug
| Alendronate | 43 | $425 | $10 |
2020: 4 drugs
| Strensiq | 12 | $863,010 | $71,918 |
| Forteo | 42 | $150,778 | $3,590 |
| Alendronate | 47 | $492 | $10 |
| Levothyroxine | 11 | $137 | $12 |
2019: 3 drugs
| Forteo | 27 | $113,392 | $4,200 |
| Raloxifene | 13 | $1,094 | $84 |
| Alendronate | 44 | $418 | $9 |
2018: 4 drugs
| Forteo | 57 | $212,442 | $3,727 |
| Raloxifene | 12 | $1,036 | $86 |
| Alendronate | 51 | $394 | $8 |
| Hydrochlorothiazide | 12 | $42 | $4 |
2017: 2 drugs
| Forteo | 65 | $238,748 | $3,673 |
| Alendronate | 57 | $441 | $8 |
2016: 3 drugs
| Forteo | 39 | $100,908 | $2,587 |
| Raloxifene | 16 | $2,346 | $147 |
| Alendronate | 49 | $309 | $6 |
2015: 2 drugs
| Raloxifene | 25 | $5,956 | $238 |
| Alendronate | 28 | $266 | $9 |
2014: 2 drugs
| Raloxifene | 24 | $5,199 | $217 |
| Alendronate | 22 | $183 | $8 |
Money from drug and device companies
$149 in 2025
| 2025 | 1 | 1 | None | $149 |
| 2024 | 3 | 5 | None | $618 |
| 2021 | 1 | 1 | None | $22 |
| 2019 | 2 | 2 | None | $234 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | None | $149 | 1 payment
|
See the published payment
| Abbvie | Meals · 2025-04-18 | None | $149 |
See earlier years (2024, 2021, 2019)
2024: $618
| Kyowa Kirin | Crysvita | $241 | 3 payments
|
| Abbvie | None | $236 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $140 | 1 payment
|
2021: $22
| Horizon Therapeutics plc | Tepezza | $22 | 1 payment
|
2019: $234
| Alexion Pharmaceuticals | Strensiq | $125 | 1 payment
|
| Amgen | Evenity | $109 | 1 payment
|
Professional record
- NPI
- 1912926890
- Licence
- CA G76662California G76662: Current · expires 2027-05-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G766620
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RG0300X (207RG0300X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-19
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.